Lourdes Felix

CIK: 0001569735

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)9 (90.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (10.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (6)

ALBT

Avalon GloboCare Corp.

Director

LIXT

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Director

PMAX.

Powell Max Ltd

Director

MEHA

Functional Brands Inc.

Director

LRHC

La Rosa Holdings Corp.

Director

BICX

BioCorRx Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Jul 1, 2026
Award(A)
Direct
30K shares-
ALBT
Avalon GloboCare Corp.
Jun 29, 2026
Award(A)
Options (right to buy)
Direct
100K shares-
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Apr 15, 2026
Award(A)
Direct
25K shares-
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Apr 15, 2026
Disposition(D)
Stock Option (right to buy)
Direct
25K shares-
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Dec 24, 2025
Award(A)
Stock Option (right to buy)
Direct
25K shares-
LRHC
La Rosa Holdings Corp.
Aug 11, 2025
Award(A)
Direct
600 shares-
BICX
BioCorRx Inc.
Dec 31, 2024
Award(A)
Direct
13.2K shares-
BICX
BioCorRx Inc.
Sep 30, 2024
Award(A)
Direct
15.6K shares-
BICX
BioCorRx Inc.
Jul 2, 2024
Award(A)
Direct
500K shares-
BICX
BioCorRx Inc.
Apr 24, 2024
Award(A)
Direct
224.2K shares-

		Type	Shares	Price		Ownership
Jul 1, 2026	LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC.	Award(A)	30,000	-	$0	Direct
Jun 29, 2026	ALBT Avalon GloboCare Corp.	Award(A) Options (right to buy)	100,000	-	-	Direct
Apr 15, 2026	LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC.	Award(A)	25,000	-	$0	Direct
Apr 15, 2026	LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC.	Disposition(D) Stock Option (right to buy)	25,000	-	-	Direct
Dec 24, 2025	LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC.	Award(A) Stock Option (right to buy)	25,000	-	-	Direct
Aug 11, 2025	LRHC La Rosa Holdings Corp.	Award(A)	600	-	-	Direct
Dec 31, 2024	BICX BioCorRx Inc.	Award(A)	13,158	-	$0	Direct
Sep 30, 2024	BICX BioCorRx Inc.	Award(A)	15,625	-	$0	Direct
Jul 2, 2024	BICX BioCorRx Inc.	Award(A)	500,000	-	$0	Direct
Apr 24, 2024	BICX BioCorRx Inc.	Award(A)	224,196	-	$0	Direct

1-10 of 10 transactions

About Felix Lourdes

Felix Lourdes (SEC CIK 0001569735) files insider reports with the SEC as Director of Avalon GloboCare Corp. (ALBT), Director of LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) and Director of Powell Max Ltd (PMAX.). Signal8 also holds filings tied to 3 other companies.

Signal8 holds 9 ownership filings by Felix Lourdes (3 Form 3, 6 Form 4), filed between Jan 31, 2025 and Jul 13, 2026. Those filings report 10 transactions, from Apr 24, 2024 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Felix Lourdes's filings is in BOCA RATON, FL.

Recent filings by Felix Lourdes

Jul 1, 2026: Grant or award of LIXT shares (Form 4, code A).
Jun 29, 2026: Grant or award of ALBT derivative securities (Form 4, code A).
Apr 15, 2026: Grant or award of LIXT shares (Form 4, code A).
Apr 15, 2026: Disposition to issuer transaction of LIXT derivative securities (Form 4, code D).
Dec 24, 2025: Grant or award of LIXT derivative securities (Form 4, code A).

Other insiders filing for Avalon GloboCare Corp. (ALBT)

Lu Wenzhao, Director
Sanders Steven Andrew, Director
Li Meng, Interim CEO
Ingargiola Luisa, Chief Strategy Officer

How to read Form 4 transaction codes